Bahhnassy et al. (2015) further linked VEGF-A to TGF-β and IGF-1R signaling, suggesting that silibinin’s anti-angiogenic properties observed in other cancers could synergize with its TGF-β2 inhibition to suppress PD-L1 [76]. The gene discussed is CD274; the disease is cancer.